Find Answers. Take Action.
Your Essential Partner in Cancer Care.
Visit us at Booth 13019 at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to learn more about how we’re delivering comprehensive genomic insights to help providers and researchers find answers and take action on innovative treatment options for patients with cancer.
Our team will be on-site to discuss:
How our proven portfolio of tests, including FoundationOne Liquid CDx, the broadest FDA-approved liquid biopsy, can help guide treatment strategies for patients with advanced cancer.
Our commitment to simplifying report interpretation, including recent enhancements we’ve made to our test reports to increase visibility to all actionable findings
Our integrations with leading EMRs, designed to improve workflow efficiency and help simplify the clinical decision-making process